Temazepam
Product Images NDC 43353-152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temazepam (NDC 43353-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 7.5mg (43353 152)

Bottle Label 7.5mg (43353 152)
Label for Temazepam 7.5 mg capsules, containing 30 capsules per container. The product is labeled as a Schedule IV controlled substance and is for prescription use only. The label shows the labeler as Aphena Pharma Solutions - Tennessee, LLC, with manufacturing and repackaging details from Somerset, NJ. Warning about habit-forming potential is also included.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

C:\documents And Settings\spolina\desktop\tem-spl\structure.jpg (Temazepam Capsules 1)

C:\documents And Settings\spolina\desktop\tem-spl\structure.jpg (Temazepam Capsules 1)
Chemical structure diagram of Temazepam, showing its molecular composition including a chlorinated benzodiazepine ring and functional groups such as hydroxyl and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.